ClinicalTrials.Veeva

Menu

The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome

H

Hadassah Medical Center

Status and phase

Unknown
Phase 2

Conditions

Post Thrombotic Syndrome

Treatments

Device: ActiveCare+S.F.T 3rd generation

Study type

Interventional

Funder types

Other

Identifiers

NCT01637428
727209-HMO-CTIL

Details and patient eligibility

About

The use of ActiveCare+S.F.T 3rd generation (an Intermittent Pneumatic Compression Device) will improve quality of life in patients suffering from Post Thrombotic Syndrome compared to compression stockings which is the current gold standard of care.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who have developed post Thrombotic leg symptoms after a deep vein thrombosis event.

Exclusion criteria

  • admitted patients
  • Patients who suffer from peripheral artery disease.
  • Patients with an acute deep vein thrombosis.
  • s/p leg skin transplant
  • Patients with an active leg infection
  • Patients who aren't capable of operating the device.

Trial contacts and locations

1

Loading...

Central trial contact

Hadas Lemberg, PhD; Galia Spectre, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems